💊 Medicine Name:
Dacarbazine
💉 Formulation:
Lyophilized Powder for Injection – for intravenous (IV) use after reconstitution
💪 Strength:
500 mg per vial
📜 Description:
Dacarbazine is an antineoplastic (chemotherapy) agent used mainly for the treatment of Hodgkin lymphoma and malignant melanoma. It is a cytotoxic alkylating-like agent that interferes with cancer cell replication by damaging DNA.
🌿 Nature:
- Triazene-based alkylating agent
- Cell cycle–nonspecific
- Prodrug requiring hepatic activation
- Used in combination chemotherapy regimens (e.g., ABVD for Hodgkin lymphoma)
🌟 Advantages:
- Essential component in the ABVD regimen for Hodgkin lymphoma, known for high cure rates
- Effective monotherapy for advanced or metastatic malignant melanoma
- The 500 mg strength is particularly suitable for higher dosing requirements in adult patients, reducing the number of vials needed per dose
- Can be used in curative or palliative settings, depending on cancer type and stage
- Longstanding clinical experience with established efficacy and toxicity profile
🧾 Prescription:
- Prescription-only medicine (Rx)
- Should only be used under supervision of an oncologist or in a specialized chemotherapy center
🎯 Indications / Uses:
- Hodgkin lymphoma – commonly in combination regimens
- Metastatic malignant melanoma – especially when other therapies are unsuitable
- May also be used in soft tissue sarcomas, neuroendocrine tumors, and testicular cancer (off-label)
📦 Packaging:
- Supplied in glass vials as a lyophilized sterile powder
- Requires reconstitution with sterile water for injection
- Final solution must be further diluted in IV fluids before use
- Cytotoxic precautions required during handling and administration
🧊 Storage:
- Store unopened vials at 15–25°C
- Protect from light and moisture
- Once reconstituted, use immediately or store as per manufacturer’s instructions
- Do not freeze the reconstituted product
👨⚕️ Patient Advice:
- Administered in-hospital only with trained personnel
- Monitor for nausea, vomiting, low blood counts
- Avoid contact with people who are ill due to immunosuppression
- Stay hydrated and report symptoms like fever, bleeding, or persistent fatigue
- Patients may need anti-nausea medication prior to administration